Kartik Ramamoorthi
Co-founder, Chief Executive Officer & Board Member @ Encoded Therapeutics
About Kartik Ramamoorthi
Kartik Ramamoorthi is the co-founder and CEO of a biotech company, known for his educational background in neuroscience from MIT and Rutgers University, and his recognition in multiple prestigious under-40 lists.
Known information
Kartik Ramamoorthi serves as the co-founder, Chief Executive Officer, and a Board Member at his biotech firm. He completed his Ph.D. in Molecular & Cellular Neuroscience from the Massachusetts Institute of Technology (MIT) in 2014, after earning a B.S. in Cell Biology and Neuroscience from Rutgers University in 2008. Ramamoorthi was part of the foundational team at Voyager Therapeutics before establishing his own company. His contributions to the biotech field have been acknowledged widely, earning him spots on several notable lists including the San Francisco Business Times 40 Under 40 in 2021, Fortune 40 Under 40 in 2020, Endpoints 20 Under 40 in 2020, Goldman Sachs 100 Most Intriguing Entrepreneurs in 2019, and Business Insider’s 30 Biotech Leaders Under 40 Shaping the Future of Medicine in 2017.
About Encoded Therapeutics
Encoded Therapeutics focuses on developing precision gene therapies for pediatric central nervous system disorders, with its leading program, ETX101, targeting Dravet syndrome.